{"disease":{"id":"progressive-primary-aphasia","name":"progressive primary aphasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03076671","title":"More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":783,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT05386394","title":"Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03153371","title":"Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03887481","title":"Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT02873546","title":"tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":52,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT03406429","title":"rTMS as a Treatment for PPA","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04188067","title":"TMS for the Treatment of Primary Progressive Aphasia","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT04883229","title":"tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}